

* NICE previously denied NHS coverage for Enhertu over cost-effectiveness concerns


(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd are progressing towards a deal which could bring access to breast cancer drug Enhertu for ...


(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday:


(Alliance News) - UK economic data showed mixed signals, as the economy stalled in January despite an improvement in the country's trade balance, whil...


(Alliance News) - Stock prices in London closed lower on Thursday, after Iran's new leader called for the Strait of Hormuz to "remain closed", raising...


(Sharecast News) - UBS upgraded Rentokil Initial on Thursday to 'buy' from 'neutral' and lifted the price target to 540p from 430p.


(Alliance News) - Stock prices in London were slightly lower at midday on Thursday, as energy market volatility and mounting concerns over the inflati...


(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:


(Alliance News) - Brent crude surged back above the USD100 mark after fresh attacks on cargo ships in the Gulf heightened supply fears.


(Alliance News) - Stock prices in London closed lower on Wednesday, as uncertainty around the length of the war in the Middle East persisted and fears...